BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17707731)

  • 1. Coronary restenosis: a new strategy for the future?
    Pelliccia F; Pasceri V
    Lancet; 2007 Aug; 370(9587):541-2. PubMed ID: 17707731
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study.
    Koo BK; Kim YS; Park KW; Yang HM; Kwon DA; Chung JW; Hahn JY; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS
    Lancet; 2007 Aug; 370(9587):567-74. PubMed ID: 17707751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial.
    Bangalore S; Khianey S; Messerli FH
    Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fighting restenosis - never-ending story].
    Przewłocki T
    Kardiol Pol; 2010 Sep; 68(9):994-5. PubMed ID: 20859887
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention of postangioplasty restenosis].
    Kitai T; Ishiwata S; Yamaguchi T
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():627-31. PubMed ID: 12735042
    [No Abstract]   [Full Text] [Related]  

  • 6. In-stent restenosis: 3 novel solutions show promise for heart patients. Stopping regrowth of plaque inside stents is a priority in reducing the need for repeat revascularizations.
    Duke Med Health News; 2007 Mar; 13(3):3-4. PubMed ID: 17385240
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets and endothelium: two key players in percutaneous coronary intervention.
    Bonello L; Sabatier F; Camoin-Jau L; Paganelli F; Dignat-George F
    Arch Cardiovasc Dis; 2011 Dec; 104(12):601-3. PubMed ID: 22152511
    [No Abstract]   [Full Text] [Related]  

  • 8. [Self-expanding stent].
    Kadota K; Mitsudo K
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):942-6. PubMed ID: 12436642
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of drug-eluting stent restenosis.
    Ishikawa K; Aoyama Y; Hirayama H
    J Invasive Cardiol; 2012 Apr; 24(4):178-82. PubMed ID: 22477755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial result of Gianturco-Roubin coronary stent].
    Tateyama H; Katoh O; Kobayashi T; Shibata N
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):954-60. PubMed ID: 12436644
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib to prevent restenosis--results from the COREA-TAXUS trial.
    Doggrell SA
    Expert Opin Pharmacother; 2008 Feb; 9(2):339-41. PubMed ID: 18201156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of high-risk patients: diabetes and small vessels.
    Kereiakes D
    J Invasive Cardiol; 2004 Sep; 16 Suppl F():3F-7F; discussion 18F-21F. PubMed ID: 23573646
    [No Abstract]   [Full Text] [Related]  

  • 13. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
    Finn AV; Nakazawa G; Kolodgie FD; Virmani R
    JACC Cardiovasc Interv; 2009 Apr; 2(4):300-2. PubMed ID: 19463440
    [No Abstract]   [Full Text] [Related]  

  • 14. Stent thrombosis: nightmare of the interventional cardiology era.
    Karakurt O; Akdemir R
    Int J Cardiol; 2011 May; 148(3):e51-2. PubMed ID: 19285352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From bench to Paccocath.
    Cremers B; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K23-31. PubMed ID: 22027724
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreasing restenosis following angioplasty: the potential of peroxisome proliferator-activated receptor gamma agonists.
    Fonseca VA; Diez J; McNamara DB
    Diabetes Care; 2004 Nov; 27(11):2764-6. PubMed ID: 15505021
    [No Abstract]   [Full Text] [Related]  

  • 18. In-stent restenosis.
    Kim MS; Dean LS
    Cardiovasc Ther; 2011 Jun; 29(3):190-8. PubMed ID: 20406239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoatherosclerosis: fooling mother nature.
    King SB
    JACC Cardiovasc Interv; 2014 May; 7(5):579-80. PubMed ID: 24852808
    [No Abstract]   [Full Text] [Related]  

  • 20. What is "the matter" with restenosis in 2002?
    Sousa JE; Costa MA; Sousa AG
    Circulation; 2002 Jun; 105(25):2932-3. PubMed ID: 12081980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.